CJC-1295 (no DAC) – 5mg + Ipamorelin – 5mg
Dual Peptide Research Blend

For Laboratory and In-Vitro Research Only

This combined set features two highly studied peptides frequently used together in controlled laboratory environments to investigate pathways related to growth hormone modulation, cellular signaling, and metabolic function. When paired, CJC-1295 (no DAC) and Ipamorelin provide a complementary model for examining pulsatile GH release mechanisms without altering natural hormonal rhythms.

Included in the Set:
• CJC-1295 (no DAC) – 5mg
A growth hormone–releasing hormone analog (GHRH) evaluated for its ability to support short-acting, physiologic GH pulse studies, making it ideal for research requiring controlled, non-prolonged receptor stimulation.

• Ipamorelin – 5mg
A selective growth hormone secretagogue (GHRP) widely researched for its high receptor specificity and minimal off-target activity. Commonly explored in models focused on GH pathway activation, cellular regeneration, and metabolic signaling.

Key Features:
• Two-component peptide system optimized for synergy in research models
• High-purity lyophilized peptides
• Supports studies on GH pulsatility, recovery pathways, and cellular regulation
• Packaged separately for flexible protocol design

Specifications:
• Total Peptides: 10mg (5mg CJC-1295 no DAC + 5mg Ipamorelin)
• Form: Lyophilized powders
• Storage: Store unmixed vials in a cool, dry place. Refrigerate after reconstitution.
• Reconstitution: Use bacteriostatic water or other lab-approved solvent.

Intended Use:
For professional laboratory research only. Designed for in-vitro studies exploring hormonal signaling, recovery biology, and cellular pathways related to GH release.

Disclaimer:
Not for human or veterinary use. Not for injection. For research purposes only. Must be handled by trained and qualified investigators.